Madrigal Pharmaceuticals Statistics
Total Valuation
MDGL has a market cap or net worth of $6.82 billion. The enterprise value is $6.01 billion.
Important Dates
The next confirmed earnings date is Thursday, May 1, 2025, before market open.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MDGL has 22.08 million shares outstanding. The number of shares has increased by 13.83% in one year.
Current Share Class | 22.08M |
Shares Outstanding | 22.08M |
Shares Change (YoY) | +13.83% |
Shares Change (QoQ) | +0.84% |
Owned by Insiders (%) | 8.37% |
Owned by Institutions (%) | 68.02% |
Float | 11.36M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 36.47 |
Forward PS | 11.50 |
PB Ratio | 9.01 |
P/TBV Ratio | 9.10 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 33.37 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.10, with a Debt / Equity ratio of 0.16.
Current Ratio | 6.10 |
Quick Ratio | 5.79 |
Debt / Equity | 0.16 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -33.94 |
Financial Efficiency
Return on equity (ROE) is -80.35% and return on invested capital (ROIC) is -44.57%.
Return on Equity (ROE) | -80.35% |
Return on Assets (ROA) | -36.98% |
Return on Invested Capital (ROIC) | -44.57% |
Return on Capital Employed (ROCE) | -57.03% |
Revenue Per Employee | $341,161 |
Profits Per Employee | -$882,371 |
Employee Count | 528 |
Asset Turnover | 0.21 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.89% in the last 52 weeks. The beta is -0.69, so MDGL's price volatility has been lower than the market average.
Beta (5Y) | -0.69 |
52-Week Price Change | +44.89% |
50-Day Moving Average | 328.62 |
200-Day Moving Average | 290.01 |
Relative Strength Index (RSI) | 45.33 |
Average Volume (20 Days) | 341,341 |
Short Selling Information
The latest short interest is 4.00 million, so 18.11% of the outstanding shares have been sold short.
Short Interest | 4.00M |
Short Previous Month | 4.09M |
Short % of Shares Out | 18.11% |
Short % of Float | 35.20% |
Short Ratio (days to cover) | 11.29 |
Income Statement
In the last 12 months, MDGL had revenue of $180.13 million and -$465.89 million in losses. Loss per share was -$21.90.
Revenue | 180.13M |
Gross Profit | 173.90M |
Operating Income | -497.88M |
Pretax Income | -510.45M |
Net Income | -465.89M |
EBITDA | -496.78M |
EBIT | -497.88M |
Loss Per Share | -$21.90 |
Full Income Statement Balance Sheet
The company has $926.25 million in cash and $119.57 million in debt, giving a net cash position of $806.68 million or $36.53 per share.
Cash & Cash Equivalents | 926.25M |
Total Debt | 119.57M |
Net Cash | 806.68M |
Net Cash Per Share | $36.53 |
Equity (Book Value) | 754.38M |
Book Value Per Share | 34.28 |
Working Capital | 863.65M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$455.57 million and capital expenditures -$1.46 million, giving a free cash flow of -$457.03 million.
Operating Cash Flow | -455.57M |
Capital Expenditures | -1.46M |
Free Cash Flow | -457.03M |
FCF Per Share | -$20.70 |
Full Cash Flow Statement Margins
Gross margin is 96.54%, with operating and profit margins of -276.39% and -258.64%.
Gross Margin | 96.54% |
Operating Margin | -276.39% |
Pretax Margin | -258.64% |
Profit Margin | -258.64% |
EBITDA Margin | -275.78% |
EBIT Margin | -276.39% |
FCF Margin | n/a |
Dividends & Yields
MDGL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -13.83% |
Shareholder Yield | -13.83% |
Earnings Yield | -6.83% |
FCF Yield | -6.70% |
Dividend Details Analyst Forecast
The average price target for MDGL is $354.75, which is 14.69% higher than the current price. The consensus rating is "Buy".
Price Target | $354.75 |
Price Target Difference | 14.69% |
Analyst Consensus | Buy |
Analyst Count | 10 |
Revenue Growth Forecast (5Y) | 83.01% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MDGL has an Altman Z-Score of 8.33 and a Piotroski F-Score of 2.
Altman Z-Score | 8.33 |
Piotroski F-Score | 2 |